Reader Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies
- 26 January 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Neurology
- Vol. 96 (4) , 186-188
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodiesNeurology, 2020
- Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 yearJournal of Neuroimmunology, 2018
- Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective studyEuropean Journal of Neurology, 2017
- Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2017
- Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patientsAnnals of Neurology, 2017
- Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology, 2016